Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2010 | 09-2009 | 09-2008 | 09-2007 | 09-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 545,861 | 451,678 | 394,761 | 368,467 | 363,537 |
| Marketable Securities | 302,269 | 283,808 | 119,667 | 231,217 | 122,162 |
| Receivables | 54,257 | 22,981 | 27,650 | 28,165 | 23,550 |
| Inventories | 28,338 | 12,975 | 18,133 | 14,883 | 11,104 |
| Income taxes - deferred | 102,758 | 83,438 | 91,824 | 73,686 | 44,568 |
| TOTAL | $1,060,413 | $900,838 | $691,869 | $733,418 | $572,632 |
| Non-Current Assets | |||||
| PPE Net | 94,097 | 92,178 | 87,915 | 85,552 | 76,995 |
| Investments And Advances | 190,837 | 205,938 | 180,996 | 73,224 | 32,909 |
| Intangibles | 331,599 | 343,156 | 333,416 | 74,753 | 38,142 |
| Other Non-Current Assets | 34,826 | 39,205 | 41,950 | 24,750 | 18,610 |
| TOTAL | $651,359 | $680,477 | $644,277 | $258,279 | $166,656 |
| Total Assets | $1,711,772 | $1,581,315 | $1,336,146 | $991,697 | $739,288 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,624 | 1,593 | 1,563 | 1,441 |
| Accounts payable and accrued liabilities | 3,606 | 12,921 | 10,137 | 9,281 | 4,581 |
| Accrued Expenses | 144,608 | 100,901 | 146,788 | 109,787 | 74,755 |
| TOTAL | $165,756 | $156,584 | $200,673 | $143,204 | $92,854 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 5,825 | 7,782 | 9,691 | 10,893 |
| Deferred Revenues | 9,647 | 37,204 | 37,344 | 13,522 | 6,358 |
| Other Non-Current Liabilities | 27,635 | 30,114 | 53,938 | 36,573 | 36,690 |
| TOTAL | $51,337 | $61,626 | $86,220 | $51,337 | $52,146 |
| Total Liabilities | $217,093 | $218,210 | $286,893 | $194,541 | $145,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 111,862 | 114,026 | 112,581 | 110,386 | 108,425 |
| Common Shares | 112 | 113 | 112 | 110 | 107 |
| Retained earnings | 1,135,922 | 852,475 | 609,495 | 409,749 | 266,918 |
| Other shareholders' equity | 28,743 | 31,538 | 4,739 | 11,467 | 3,814 |
| TOTAL | $1,494,679 | $1,363,105 | $1,049,253 | $797,156 | $594,288 |
| Total Liabilities And Equity | $1,711,772 | $1,581,315 | $1,336,146 | $991,697 | $739,288 |